RecruitingPhase 2NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Sponsor: Celgene
Washington D.C., DC · +58 more sites
4 recruiting alzheimer's disease studies with a site in Washington D.C., DC.
All trials in Washington D.C., DC · All Alzheimer's Disease trials
Sponsor: Celgene
Washington D.C., DC · +58 more sites
Sponsor: Bristol-Myers Squibb
Washington D.C., DC · +27 more sites
Sponsor: Eidos Therapeutics, a BridgeBio company
Washington D.C., DC · +39 more sites
Sponsor: Georgetown University
Washington D.C., DC
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.